<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="40" ids="18243">Dopamine</z:chebi>, 1-10 micrograms/kg body weight/min was infused in 6 patients suffering from cerebrovascular diseases with <z:e sem="disease" ids="C0151740" disease_type="Disease or Syndrome" abbrv="">elevated intracranial pressure</z:e> and a critical cerebral perfusion pressure </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="40" ids="18243">Dopamine</z:chebi> decreased intracranial pressure in 3 and increased it moderately in the other 3 patients </plain></SENT>
<SENT sid="2" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> patients, the <z:chebi fb="40" ids="18243">dopamine</z:chebi>-induced rise of mean arterial pressure led to an increase of cerebral perfusion pressure </plain></SENT>
<SENT sid="3" pm="."><plain>Transcranial Doppler ultrasonographic recordings of the middle cerebral artery in patients whose intracranial pressure declined revealed a decrease of the pathologically elevated cerebrovascular resistance, and an augmentation of cerebral blood supply </plain></SENT>
<SENT sid="4" pm="."><plain>In conclusion, <z:chebi fb="40" ids="18243">dopamine</z:chebi> infusions may improve cerebral hemodynamics in some patients with severe <z:hpo ids='HP_0002181'>brain edema</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Such patients can be identified by intracranial pressure and Doppler monitoring </plain></SENT>
</text></document>